First-in-Human Safety and Efficacy Study on Combination of High-Intensity Focused Ultrasound Sonication and Micellar Nanoparticle-Encapsulated Epirubicin, K-912; a Novel Sonodynamic Therapy for the Treatment of Refractory Abdominal Cancersの表示

##article.return## First-in-Human Safety and Efficacy Study on Combination of High-Intensity Focused Ultrasound Sonication and Micellar Nanoparticle-Encapsulated Epirubicin, K-912; a Novel Sonodynamic Therapy for the Treatment of Refractory Abdominal Cancers ダウンロード PDFをダウンロード